<DOC>
	<DOC>NCT01504412</DOC>
	<brief_summary>The purpose of this study is to investigate the effectiveness and safety of DS-5565, compared to placebo, in subjects with pain associated with diabetic peripheral neuropathy.</brief_summary>
	<brief_title>Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuorpathy</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Type 1 or Type 2 diabetes mellitus Painful distal symmetric polyneuropathy Average daily pain score is great than or equal to 4 HbA1c greater than 9.0</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Pain</keyword>
	<keyword>Diabetic Peripheral Neuropathy</keyword>
</DOC>